Abstract. The proto-oncoprotein c-Ets1 is a well-known transcription factor that belongs to the Ets family and plays a role in haematopoietic differentiation, angiogenesis, and carcinogenesis. Ets family members share a unique DNA binding domain, the Ets domain, and are known to control DNA binding activity and transcriptional activation by autoinhibition. In c-Ets1 the DNA binding domain as well as N-terminal and C-terminal inhibitory domains are involved in autoinhibitory regulation. It has been proposed that intramolecular interactions are part of the autoinhibitory mechanism. We applied a GST pull-down assay as well as a two-hybrid system in yeast to show an interaction between the DNA binding domain of c-Ets1 and a domain N-terminal thereof. We have mapped the interaction sites within both of the c-Ets1 domains. Comparison of the analogous intramolecular interaction in c-Ets1 and in v-Ets revealed that the interaction we detected is stronger in v-Ets than in c-Ets1. In view of previous findings from DNA binding studies, and kinetic experiments as well as structural data, our results suggest a new model as to how intramolecular interactions might participate in the regulation of DNA binding. Binding of c-Ets1 to DNA temporarily changes the intramolecular pattern of interaction in c-Ets1, leading to an increase in affinity of c-Ets1 to DNA. In full-length c-Ets1 the intramolecular interactions re-form spontaneously and the protein-DNA complex dissociates. The interaction we characterize herein might increase the DNA binding affinity temporarily in DNA-bound c-Ets1. In v-Ets in which the C-terminal domain is mutated this interaction appears to lead to strong DNA binding affinity.
Introduction
The proto-oncoprotein c-Ets1 and its viral homologue v-Ets are members of the Ets family of transcription factors (1) . C-Ets1 is expressed by a broad variety of cells. In haematopoietic cells, it contributes to the regulation of cellular differentiation. C-Ets1 plays a role in the regulation of angiogenesis during development, wound healing and tumor angiogenesis. Upon activation by angiogenic factors such as vascular endothelial growth factor (VEGF), endothelial cells transiently produce c-Ets1 resulting in proliferation, migration and invasion (2, 3) . Together with hypoxia inducible factor (HIF)-2α, c-Ets1 can activate transcription of VEGF receptor-2 (VEGFR-2, KDR, flk-1), by cooperative binding to the VEGFR-2 promotor (4). C-Ets1 is produced by a variety of solid tumors and by the vascular stroma of cancerous lesions (5) . In epithelial cancer cells, c-Ets1 promotes invasive behaviour and c-Ets1 expression has been correlated with a poorer prognosis in breast, ovarian, and cervix carcinoma (6) (7) (8) (9) . C-Ets1 has been described to regulate expression of the matrix metalloproteases MMP1, MMP2, MMP9, and urokinase type plasminogen activator (uPA, 10), as well as that of VEGF (11) , VEGF receptor-1 (12) , and VEGF receptor-2 (4) .
The function of transcription factors is regulated by different mechanisms, in order to control the level of protein synthesis. One frequently occurring mechanism of regulation is autoinhibition. In Ets family members autoinhibition has been found to affect DNA binding activity (13, 14) . Ets family members share a unique DNA binding domain, the Ets domain, which is highly conserved among species and belongs to the superfamily of winged helix-turn-helix (wHTH) DNA binding proteins (15) . In the p68 splice variant of c-Ets1, the DNA binding domain comprises a stretch of 85 amino acids extending from residue 375 to residue 459 and includes three α-helices (H) and four ß-strands (S) arranged in the order H1 -S1 -S2 -H2 -H3 -S3 -S4. The helix H3 has been shown to interact with the specific DNA core element 5'-GGAA/T-3' (16) . Using NMR spectroscopy it has been shown that the helix H3 interacts with the major groove of the DNA core element, whereas the loop between strands 3 and 4 of the ß-sheet on the one hand and the helices H1-H3 on the other hand ONCOLOGY REPORTS 18: 457-463, 2007 457
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contribute to DNA interaction with the adjacent minor grooves (17) . v-Ets is the best characterized member of the Ets family and was the first family member to be detected in the E26 avian erythroblastosis virus. The cellular homologue of the viral v-ets is the p68 splice variant of the cellular c-ets1 gene. v-Ets differs from its cellular homologue by two point mutations and its C-terminal sequence, in which a stretch of 13 amino acids is substituted by 16 completely different amino acids as a result of DNA segment inversion (18) . The DNA binding activity of v-Ets is far stronger than that of c-Ets1, which can however be enhanced by deletion of the C-terminal 8 amino acids of c-Ets1 (19) .
In c-Ets1, the exon VII domain (amino acids 243-331), an N-terminal regulatory domain that controls the activity of the DNA binding domain, is located adjacent to the DNA binding domain. A C-terminal regulatory unit of exon VII forms part of an autoinhibitory module (20) , the inhibitory effect of which is increased by phosphorylation of an N-terminal sequence of the exon VII containing a calcium-responsive phosphorylation site (21) . Binding of c-Ets1 to DNA triggers structural changes in the exon VII domain, which in turn release repression of DNA binding (20, 22) .
DNA binding of c-Ets1 is repressed by regions C-and N-terminal of the DNA binding domain that cooperate in destabilizing the protein-DNA complex (22, 23) . In the Nterminal region the amino acids 325-355 are necessary to repress DNA binding, whereas in the C-terminal region the amino acids 473-485 are involved (22) .
Crystallographic studies of fragments of c-Ets1 have confirmed that the exon VII domain contains two helices, one of which unfolds upon Ets1 binding to DNA (24) . The Cterminal inhibitory region further contains two α-helices (25) . In earlier studies deletion of an even further N-terminal region (amino acids 207-282) was found to increase DNA binding (19) .
Both repression of DNA binding and subsequent release of this repression are induced by conformational changes within c-Ets1. Crystallographic studies suggest that an intramolecular contact between Helix H1 of the ETS domain on the one hand and the N-terminal as well as the C-terminal inhibitory region on the other forms a hydrophobic core and stabilizes the autoinhibitory module (24, 26) .
We demonstrate herein that intramolecular interactions between different domains of c-Ets1 molecule do indeed exist. We have mapped an interaction between the DNA binding domain of c-Ets1 and a domain N-terminal thereof and show that the mutated viral form exhibits a different pattern of intramolecular interactions. Possibly, the interaction described here forms part of the intramolecular mechanism in c-Ets1 leading to the autoinhibition of DNA binding, which is disrupted in its viral homologue v-Ets.
Materials and methods

Construction of plasmids for protein interaction assays in solution.
For expression of GST fusion proteins, the c-Ets1 DNA binding domain or truncations of it were cloned into the GST fusion vector pGEX-2T (27) using available restriction sites or PCR-mediated strategies. Construction of the plasmids 106, 109, 118 and 119 has been described (28 The construct M13 has been published as cetsKS (19) . In order to map the intramolecular binding site outside the DNA binding domain of Ets, truncations of c-Ets1 sequence were constructed by subcloning fragments of cetsKS into PCR II Vector (Stratagene, Heidelberg, Germany) allowing for in vitro translation of proteins. Correct in-frame transition of each sequence in the constructs M36, M40, M41, M57, M52, M39, M55 and 247 was confirmed by DNA sequencing.
GST pull-down assay. For expression and purification of GST fusion proteins, each pGEX construct was used to transform E. coli strain Xl-1 Blue (Stratagene), and resulting transformants were grown overnight in Luria-Bertani broth supplemented with 50 μg/ml ampicillin at 37˚C. When the culture reached an optical density of 0.8 at 600 nm, expression was induced by the addition of IPTG (100 μM, Sigma, Deisenhofen, Germany), followed by incubation for further 3 h at 30˚C. To purify GST proteins, cell lysates were prepared as described by Frangioni and Neel (29) and Smith et al (27) . The proteins were incubated with glutathione sepharose 4B resin (Pharmacia, Heidelberg, Germany) for 1 h at 4˚C, followed by washing with phosphate-buffered saline, 0.05% Triton X-100 and protease inhibitor cocktail tablets (Roche Diagnostics, Mannheim, Germany).
Expression of c-Ets1 and fragments was generated by in vitro translation with the TNT coupled rabbit reticulocyte lysate system (Promega, Mannheim, Germany) using T7 RNA polymerase and labelling with 100 μCi[
35 S]methionine/50 μl reticulocyte lysate. Reticulocyte lysate (5 μl) was diluted to 200 μl with binding buffer [150 mM NaCl, 50 mM Tris-HCl (pH 7.6), 0.05 % Triton X-100, and protease inhibitor mix]. The reticulocyte lysate was incubated with 10 μl of GST protein for 1 h at 4˚C. After 5 washes with 1 ml of binding buffer, the complexes were dissociated in 20 μl sample buffer [50 mM Tris-HCl (pH 6.8), 2% SDS, 5% ß-mercaptoethanol, 10% glycerol, 0.02% bromophenol blue] and separated by SDS-PAGE on 12.5% acrylamide gels. After staining the gels with coomassie blue, they were treated with dimethyl sulfoxide/2.5-diphenyloxazole for fluorographic exposure, dried under vacuum, and then exposed to X-ray film for 4-12 h.
Construction of plasmids for the yeast two-hybrid system.
The previously published reporter construct 27 contains several LexA binding sites, the reporter gene E. coli LacZ and uracil conferring auxotrophy (30) .
The bait plasmids carry an HIS3 marker for clonal selection and the sequence of the DNA binding domain of Lex A. Bait plasmid M25 was constructed by inserting the DNA binding domain of c-Ets1 adjacent to the Lex A DNA binding domain in the 10 kb vector pEG 200+4 (30) . Correct in-frame transition was confirmed by DNA sequencing. Plasmid 86 contains the DNA binding domain of Lex A and a fusion protein lacking a binding capacity for DNA or c-Ets1 (28) . Plasmid 41 contains the Lex A DNA binding domain only (28) . Plasmid pRS423 carries the HIS3 marker but does not encode for a fusion protein (31) . Plasmids 86, 41 and pRS423 served as negative controls. Plasmid G1 encoding for a protein fused to the DNA binding domain of Lex A, together with the interacting protein G2 fused to the transactivation domain of VP16, served as a positive control for interaction in the yeast two-hybrid system (Superti-Furga G, personal communication).
The interacting plasmid M17 contains the sequence of c-Ets1 fused to the transactivation domain of VP16. M19 contains the amino acids 1-408 fused to VP16. Correct in-frame transition was confirmed by sequencing.
Expression and transactivation assay in Saccharomyces cerevisiae. For each experiment, the Saccharomyces cerevisiae strain W303-1A (MATa, ho, his3-11, 15; trp1-1; ade2-1; leu2-3,112; ura3; can1-100) was transformed with three different plasmids using a lithium acetate method as described previously (28) . Cells were plated on selective glucose plates lacking histidine, tryptophane, and uracil. After 48 h, when small colonies appeared, they were re-cultivated on selective X-gal containing indicator plates. In the event of interaction between the Lex A DNA binding domain fusion protein and the VP16 fusion protein blue colonies appeared. In addition to visual analysis, single colonies were re-cultivated on selective plates from which triplicate cultures in 1 ml selective synthetic galactose medium for each condition were inoculated and incubated for 24 h at 30˚C. Cells were harvested by centrifugation, washed, permeabilized by freezing on dry ice, and ONPG (Sigma) was added. ß-galactosidase activity was detected as described previously (28) . Enzyme activities were normalized to cell number as measured by the optical density of the cell suspension at 600 nm.
Results
Identification of an interaction between the DNA binding domain of c-Ets1 and the N-terminal part of the molecule.
We used a glutathione S-transferase (GST) pull-down assay to investigate whether the DNA binding domain interacts with other domains of c-Ets1. A fusion protein comprising the DNA binding domain and the C-terminal inhibitory domain of c-Ets1 adjacent to the C-terminus of GST was produced using construct 118, isolated, immobilized on a glutathione affinity matrix, and incubated with in vitro translated 
Mapping the interaction site within the DNA binding domain.
We designed a series of deletion mutants of the DNA binding domain fused to GST to localize the interaction site within the DNA binding domain. The fusion proteins were isolated, immobilized, and incubated with in vitro translated [
35 S]methionine-labelled c-Ets1 lacking the DNA binding domain (M36). As shown in Fig. 2 , deletion of the c-Ets1-specific C-terminal 23 amino acids (129) increases the interaction with M36, whereas further C-terminal deletion (130) decreases this interaction. N-terminal deletions up to amino acid 395 do not affect the interaction. The deletion mutant comprising amino acids 395-462 (124) shows the strongest interaction with M36. This mutant contains all four ß-strands and the α-helices H2 and H3. Thus, the helix H1 that has been shown to play a major role in the inhibitory function of the c-Ets1 molecule (24) does not seem to participate in the interaction with the N-terminal part of the molecule. Helix H4/H5 located in the C-terminal region of c-Ets-1, which has also been shown to be part of the inhibitory complex (22, 24) , seems to disturb the interaction between the DNA binding domain and the remaining molecule, since a deletion leads to an increase of interaction.
The DNA binding domain of v-Ets exhibits stronger interaction with the N-terminal part of the protein than the DNA binding domain of c-Ets1.
To focus on the role of the C-terminal region in the interaction between the DNA binding domain and the N-terminal part of the molecule, we designed a fusion protein comprising the v-Ets DNA binding domain and GST and tested it for interaction with in vitro translated and radioactively labelled M36. V-Ets differs from c-Ets1 by the C-terminal amino acids and two point mutations within the DNA binding domain. As shown in Fig. 3 , the DNA binding domain of v-Ets (construct M28) interacts more strongly with M36 than the DNA binding domain of c-Ets1 (construct 118). The Cterminal domain of c-Ets1 therefore seems to inhibit the interaction of the DNA binding domain with the N-terminus (Fig. 4) and C-terminal deletions up to amino acid 285. Internal deletions lacking the amino acids 110-175 (M55) were bound by GST fusion protein 124, whereas internal deletions lacking the amino acids 175-280 were not bound. Hence, the amino acids 175-280 seem to be necessary for the interaction between the DNA binding domain of c-Ets1 and an N-terminal area thereof.
Confirmation of the interaction between the DNA binding domain of c-Ets1 and the N-terminal part of the molecule in a yeast two-hybrid system.
To confirm the interaction we found in a biochemical assay in a biological system, we designed a yeast two-hybrid system using the DNA binding domain of c-Ets1 as bait, fused to the heterologous DNA binding domain of Lex A (fusion protein M25). We constructed two potentially interacting sequences, the full-length c-Ets1 (M17) on the one hand and a c-Ets1 variant lacking the DNA binding domain (M19) on the other, in a yeast expression vector tagged to the transcriptional activation domain from VP16 of Herpes simplex virus. Reporter plasmid, plasmids with Lex A fusion proteins as well as plasmids with VP16 fusion proteins were transfected into a yeast strain. To avoid counter selection of colonies in which protein interactions would result in a growth disadvantage, cells were initially plated on selective glucose medium, where transcription of the fusion proteins was repressed. As soon as small colonies had appeared, they were shifted to galactose medium containing X-Gal as indicator for enzyme activity.
In addition to optical evaluation, the enzyme activity as indicator for interaction between the fusion proteins was quantified using a ß-galactosidase assay. In Fig. 5 , the DNA binding domain is shown to interact with full-length c-Ets1 (column A) as well as with the c-Ets1 variant lacking the DNA binding domain (column B). As negative controls, we used a protein fused to Lex A that does not bind c-Ets1 or DNA (plasmid 86, columns C and D), a plasmid carrying Lex A DNA binding domain alone (plasmid 41, column E), and an empty selective plasmid (pRS 414, column F and pRS 423, column G). As a positive control, we used an established yeast two-hybrid system (provided by Superti-Furga G, personal communication, SL1 PL 29b, column H).
Applying this yeast two-hybrid system, we were able to confirm the existence of the intramolecular interaction between the DNA binding domain and an area N-terminal of the DNA binding domain in c-Ets1 (Fig. 5, columns A and B) .
Discussion
Our study provides the first direct evidence for an intramolecular interaction between the DNA binding domain of c-Ets1 and an inhibitory domain located further N-terminally. We have mapped the interaction sites to the amino acids 175-280 at the N-terminal site and to the amino acids 395-462 within the DNA binding domain. We have also shown that the pattern of intramolecular interaction is different in v-Ets. The presence of N-and C-terminal inhibitory sequences flanking the ETS domain in c-Ets1 has been described in previous studies (23) . Our data support elements of the existing model of c-Ets1 DNA binding regulation, but in addition provide evidence for further intramolecular interaction that might temporarily stabilize DNA binding of c-Ets1.
The interaction site reported and characterized herein involves the helices H2 and H3 as well as the ß-sheet of the DNA binding domain (Fig. 2) . NMR studies have revealed that, upon DNA binding, helix H3 contacts the major groove and that the wing between ß-strand S3, S4 and a loop between helices H2 and H3 form further contact sites (32) . Therefore, both the ß-sheet and the helix H2 are exposed upon DNA binding, providing a surface for the interaction with the Nterminal inhibitory domain.
DNA binding studies have shown that full-length c-Ets1 and c-Ets1 variants comprising N-terminal deletions of c-Ets1 up to amino acid 207 do not bind DNA, whereas extended deletions lead to DNA binding. The region from amino acid 207-280 has to be intact in order to repress DNA binding (19) . Our studies show that the region between amino acids (19) . This area is identical with the area we show here to interact with the DNA binding domain. A second inhibitory region between amino acids 325 and 375 was identified by Petersen et al (20) . It lies within the area encoded by Exon VII and contains two α-helices (HI-1 and HI-2). A third inhibitory domain with two α-helices was identified C-terminal of the DNA binding domain (H4/H5). A structural alliance between helix H4/H5 and the first helix within the DNA binding domain H1 was shown by nuclear Overhauser effect spectroscopy (15, 33) . As shown by crystallographic studies the helices HI-1, HI-2 and H4/H5 inhibit DNA binding of Ets proteins by interacting with helix H1 of the Ets domain to form a hydrophobic core (24) . These intramolecular interactions transiently keep the Ets domain in a closed conformation that prevents DNA binding. As the inhibitory helix HI-1 spontaneously unfolds and forms a random coil (20) the closed conformation is relieved and cEts1 can bind DNA. These structural changes allow Ets proteins to modulate DNA binding and thereby transcriptional activity (24) .
The N-terminal interaction site we identified and characterized (N1) is located further N-terminal than the inhibitory sequences HI-1 and HI-2. The interaction of N1 with the DNA binding domain is increased upon deletion or mutation of the C-terminus and the deletion of N1 results in increased DNA binding (19) . Thus, we assume that the interaction between N1 and the DNA binding domain counteracts the interaction between HI-1 and HI-2 and the 
